Keyword: NIAID

Here is some other vaccine news of note for the week.

Inovio's HIV vaccine is in early-stage development, but the company reported immune responses induced by the shot that lasted at least six months.

BiondVax enrolled its first patient in a phase 2 U.S. study of its universal flu vaccine, which aims to fight off all strains of the virus at the same time.

Here is some other vaccine news of note for the week.

Experts say technology is advancing to develop vaccines faster at a time of increasing emerging disease outbreaks.

Dubbed 2017 H7N9 IIV, the vaccine contains an inactivated H7N9 virus collected in 2017.

Here's some other vaccine news of note for the week.

GlaxoSmithKline is touting phase 3 study data showing its Fluarix Tetra can protect young children who are among the most vulnerable to the virus.

The egg-based production process might have made this season's flu shot only 10% effective.

Preliminary results from a trio of phase 1 studies showed promise for the Zika vaccine Sanofi had previously left behind.